PRESS RELEASES
-
Actamax Receives Approval to Begin Pivotal Clinical Trial for Actamax™ Adhesion Barrier
September 20, 2017
-
Actamax™ submits IDE to FDA for pivotal study on novel Sprayable Adhesion Barrier Device
February 21, 2017
-
Actamax announces presentation on 12 months clinical follow-up outcomes of novel sprayable adhesion barrier device
November 14, 2016
-
Actamax Announces Positive Results from First Clinical Trial Demonstrating Safety, Ease of use and Efficacy of Novel Sprayable Adhesion Barrier Device
November 10, 2014
-
DSM and DuPont announce joint venture in surgical biomedical materials
September 23, 2010
Copyright ©2017 DSM. All rights reserved. *Actamax Surgical Materials LLC is not offering for sale any medical device at this time. Actamax™ Adhesion Barrier is neither CE Mark certified nor FDA cleared.